FDA Approves Label Update For PREZISTA® To Include 192-Week Data In HIV-1-Infected Adult Patients Starting Treatment

Saturday, October 22nd, 2011

Janssen Therapeutics, Division of Janssen Products, LP, announced that the U.S. Food and Drug Administration (FDA) has approved a label update for PREZISTA® (darunavir) tablets to include 192-week data from the ARTEMIS study. ARTEMIS evaluated the efficacy and safety of PREZISTA with ritonavir (r) vs. lopinavir/r in combination with ...

Potential Use Of Adult Stem Cells For Human Gene Therapy

Monday, October 17th, 2011

This research, published on the Nature review website, provides evidence of a major concept could pave the way for the future use of these stem cells to treat humans, through perspective gene therapies. For several years now, scientists have been able to produce cells with stem cell properties, by using ...

Stem Cells Made From Quasi-Cloned Human Embryo

Wednesday, October 5th, 2011

By adding the nuclei of adult skin cells from patients with type 1 diabetes to unfertilized human eggs without first removing the egg DNA as was done to clone Dolly the sheep, scientists at a stem cell lab in New York have managed to reprogram the eggs to ...

Smoking Higher Among Americans With Fewer Academic Qualifications

Sunday, October 2nd, 2011

Smoking rates in the USA range from 28.4% for adults with no high school education, 28.6% among individuals with no health insurance, to 9.1% for employees with at least a bachelor's degree, according to a report "Morbidity and Mortality Weekly Report, Sept. 30, 2011" issued by the CDC (Centers for ...

Reversing Aging Process Of Human Adult Stem Cells Possible

Sunday, September 25th, 2011

Scientists who carried out a study in cell culture have demonstrated how the aging process for human adult stem cells can be reversed, opening a new avenue for therapies that could repair tissue damage linked to a wide range of diseases, authors from the Buck Institute for Research on Aging ...